Submit Manuscript  

Article Details


Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision

[ Vol. 17 , Issue. 8 ]

Author(s):

Nare Sahakyan, Amir Haddad, Shye Richardson, Valery Forcha-Etieundem, Lee Christopher, Hanan Alharbi and Robert Campbell   Pages 1033 - 1039 ( 7 )

Abstract:


Nanotechnology has brought about the advent of personalized medicine in the era of targeted therapeutic strategies for cancer therapy. The ability to exploit tumor features for therapeutic gain has made it possible to manufacture more effective nanomedicines for cancer treatment. However, known obstacles, including the inability to overcome pathophysiological barriers of tumors, have impeded disease management. In spite of this, recent efforts have been made to develop more functionalized nanosystems that utilize the active-targeting approach. This article reviews the FDA-approved cancer drug delivery systems in the general framework of personalized nanomedicine. We discuss the latest efforts in the development of functionalized nano-systems, and summarize relevant ongoing preclinical and clinical trials.

Keywords:

Personalized medicine, cancer therapy, drug delivery, nanoparticles, tumor-targeted nanomedicines, nanotechnology.

Affiliation:

Massachusetts College of Pharmacy and Health Sciences, 19 Foster St. Worcester, MA 01608, Massachusetts College of Pharmacy and Health Sciences, 19 Foster St. Worcester, MA 01608, Massachusetts College of Pharmacy and Health Sciences, 19 Foster St. Worcester, MA 01608, Massachusetts College of Pharmacy and Health Sciences, 19 Foster St. Worcester, MA 01608, Massachusetts College of Pharmacy and Health Sciences, 19 Foster St. Worcester, MA 01608, Massachusetts College of Pharmacy and Health Sciences, 19 Foster St. Worcester, MA 01608, Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences, Department of Pharmaceutical Sciences, 19 Foster St. Worcester, MA 01608

Graphical Abstract:



Read Full-Text article